Literature DB >> 17512217

A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MR.

Elizabeth Bullitt1, David A Reardon, J Keith Smith.   

Abstract

There is currently no noninvasive, reliable method of assessing brain tumor malignancy or of monitoring tumor treatment response. Monitoring changes to tumor vasculature might provide an effective means of assessing both tumor aggressiveness and treatment efficacy. To date, most such research has concentrated upon tumor "microvascular" imaging, with permeability and/or perfusion imaging used to assess vessel changes at the subvoxel level. An alternative approach assesses tumor vasculature at the "macroscopic" level, calculating the numbers and shapes of the larger vessels discriminable by magnetic resonance angiography. This paper provides an overview of magnetic resonance (MR) vascular imaging at both the microscopic (dynamic MR perfusion and permeability) and macroscopic (MR angiographic) levels. The two approaches provide different, complementary information and together could provide important insights into cancer growth as well as new methods of assessing malignancy and tumor treatment response.

Entities:  

Mesh:

Year:  2007        PMID: 17512217      PMCID: PMC2292206          DOI: 10.1016/j.neuroimage.2007.03.067

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  23 in total

Review 1.  Dynamic susceptibility contrast MRI of gliomas.

Authors:  Hannu J Aronen; Jussi Perkiö
Journal:  Neuroimaging Clin N Am       Date:  2002-11       Impact factor: 2.264

Review 2.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.

Authors:  F Yuan; Y Chen; M Dellian; N Safabakhsh; N Ferrara; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects.

Authors:  J D Hazle; E F Jackson; D F Schomer; N E Leeds
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

5.  Abnormal vessel tortuosity as a marker of treatment response of malignant gliomas: preliminary report.

Authors:  Elizabeth Bullitt; Matthew G Ewend; Stephen Aylward; Weili Lin; Guido Gerig; Sarang Joshi; Inkyung Jung; Keith Muller; J Keith Smith
Journal:  Technol Cancer Res Treat       Date:  2004-12

6.  Significance of blood vessel leakiness in cancer.

Authors:  Donald M McDonald; Peter Baluk
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

Review 7.  Dynamic magnetic resonance perfusion imaging of brain tumors.

Authors:  Diego J Covarrubias; Bruce R Rosen; Michael H Lev
Journal:  Oncologist       Date:  2004

8.  Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors.

Authors:  L Ostergaard; F H Hochberg; J D Rabinov; A G Sorensen; M Lev; L Kim; R M Weisskoff; R G Gonzalez; C Gyldensted; B R Rosen
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

9.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

10.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

View more
  16 in total

1.  Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging.

Authors:  Ketan B Ghaghada; Cristian T Badea; Lohitash Karumbaiah; Nicole Fettig; Ravi V Bellamkonda; G A Johnson; Ananth Annapragada
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

2.  Quantification of Microvascular Tortuosity during Tumor Evolution Using Acoustic Angiography.

Authors:  Sarah E Shelton; Yueh Z Lee; Mike Lee; Emmanuel Cherin; F Stuart Foster; Stephen R Aylward; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2015-04-07       Impact factor: 2.998

3.  The effects of healthy aging on intracerebral blood vessels visualized by magnetic resonance angiography.

Authors:  Elizabeth Bullitt; Donglin Zeng; Benedicte Mortamet; Arpita Ghosh; Stephen R Aylward; Weili Lin; Bonita L Marks; Keith Smith
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

Review 4.  Hierarchical microimaging of bone structure and function.

Authors:  Ralph Müller
Journal:  Nat Rev Rheumatol       Date:  2009-07       Impact factor: 20.543

5.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

Review 6.  Conventional MRI evaluation of gliomas.

Authors:  N Upadhyay; A D Waldman
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

7.  Medical record and imaging evaluation to identify arterial tortuosity phenotype in populations at risk for intracranial aneurysms.

Authors:  Karl T Diedrich; John A Roberts; Richard H Schmidt; Lisa A Cannon Albright; Anji T Yetman; Dennis L Parker
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

8.  Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.

Authors:  Andrés Server; Bjørn A Graff; Tone E Døli Orheim; Till Schellhorn; Roger Josefsen; Øystein B Gadmar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-09-21       Impact factor: 2.804

9.  Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.

Authors:  Peter S LaViolette; Alex D Cohen; Melissa A Prah; Scott D Rand; Jennifer Connelly; Mark G Malkin; Wade M Mueller; Kathleen M Schmainda
Journal:  Neuro Oncol       Date:  2013-02-03       Impact factor: 12.300

Review 10.  Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.

Authors:  David A Reardon; Patrick Y Wen; Annick Desjardins; Tracy T Batchelor; James J Vredenburgh
Journal:  Expert Opin Biol Ther       Date:  2008-04       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.